Gabelli Funds’s Evolent Health EVH Stock Holding History

Gabelli Funds’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$648K	Buy	284,300 +21,100	+8%	+$66.9K	﹤0.01%	995
2025 Q4	$1.05M	Sell	263,200 -367,000	-58%	-$2.04M	0.01%	896
2025 Q3	$5.33M	Sell	630,200 -68,600	-10%	-$666K	0.04%	473
2025 Q2	$7.87M	Sell	698,800 -9,315	-1%	-$85.6K	0.06%	366
2025 Q1	$6.71M	Buy	708,115 +9,315	+1%	+$94.1K	0.05%	385
2024 Q4	$7.86M	Sell	698,800 -22,700	-3%	-$399K	0.06%	346
2024 Q3	$20.4M	Sell	721,500 -10,500	-1%	-$271K	0.15%	196
2024 Q2	$14M	Buy	732,000 +93,500	+15%	+$2.39M	0.11%	254
2024 Q1	$20.9M	Buy	638,500 +113,000	+22%	+$3.61M	0.15%	187
2023 Q4	$17.4M	Hold	525,500	–	–	0.13%	203
2023 Q3	$14.3M	Buy	525,500 +5,000	+1%	+$139K	0.12%	238
2023 Q2	$15.8M	Hold	520,500	–	–	0.12%	223
2023 Q1	$16.9M	Buy	520,500 +63,860	+14%	+$2.02M	0.13%	219
2022 Q4	$12.8M	Buy	456,640 +11,140	+3%	+$319K	0.1%	268
2022 Q3	$16M	Sell	445,500 -5,000	-1%	-$176K	0.13%	212
2022 Q2	$13.8M	Buy	450,500 +10,000	+2%	+$291K	0.11%	263
2022 Q1	$14.2M	Sell	440,500 -22,000	-5%	-$576K	0.09%	282
2021 Q4	$12.8M	Buy	462,500 +15,000	+3%	+$430K	0.08%	301
2021 Q3	$13.9M	Sell	447,500 -103,000	-19%	-$2.47M	0.09%	278
2021 Q2	$11.6M	Sell	550,500 -25,000	-4%	-$501K	0.07%	323
2021 Q1	$11.6M	Sell	575,500 -291,500	-34%	-$5.54M	0.08%	316
2020 Q4	$13.9M	Sell	867,000 -211,500	-20%	-$2.8M	0.1%	262
2020 Q3	$13.4M	Sell	1,078,500 -68,000	-6%	-$800K	0.1%	253
2020 Q2	$8.16M	Sell	1,146,500 -11,000	-1%	-$73.7K	0.07%	338
2020 Q1	$6.29M	Hold	1,157,500	–	–	0.06%	376
2019 Q4	$10.5M	Sell	1,157,500 -53,000	-4%	-$431K	0.07%	332
2019 Q3	$8.7M	Buy	1,210,500 +179,500	+17%	+$1.29M	0.06%	374
2019 Q2	$8.2M	Buy	1,031,000 +122,500	+13%	+$1.45M	0.05%	394
2019 Q1	$11.4M	Buy	908,500 +195,000	+27%	+$3.09M	0.07%	336
2018 Q4	$14.2M	Buy	713,500 +150,000	+27%	+$3.47M	0.1%	283
2018 Q3	$16M	Sell	563,500 -160,000	-22%	-$3.82M	0.09%	299
2018 Q2	$15.2M	Sell	723,500 -60,000	-8%	-$1.14M	0.09%	306
2018 Q1	$11.2M	Buy	783,500 +30,500	+4%	+$437K	0.07%	358
2017 Q4	$9.26M	Buy	753,000 +358,000	+91%	+$5.05M	0.05%	406
2017 Q3	$7.03M	Buy	395,000 +325,000	+464%	+$6.7M	0.04%	478
2017 Q2	$1.77M	Sell	70,000 -30,000	-30%	-$722K	0.01%	804
2017 Q1	$2.23M	Buy	+100,000	New	+$1.92M	0.01%	755

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gabelli Funds's EVH Position: Q1 2026 in Review

Gabelli Funds increased its Evolent Health (EVH) stake by 8% in Q1 2026, buying an estimated $66.9K and bringing the position to 284,300 shares worth $648K. The position accounts for ﹤0.01% of the portfolio, ranked #995.

Gabelli Funds first reported a position in EVH in Q1 2017 and has held it in 37 quarters since. The position peaked at $20.9M in Q1 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

Gabelli Funds held 284,300 shares of Evolent Health worth $648K as of Q1 2026.
Gabelli Funds bought 21,100 Evolent Health shares in Q1 2026, an estimated $66.9K.
Evolent Health made up ﹤0.01% of Gabelli Funds's portfolio in Q1 2026, its #995 holding.
Gabelli Funds first reported a position in Evolent Health in Q1 2017 and has held it in 37 quarters since.
Gabelli Funds's Evolent Health position peaked at $20.9M in Q1 2024.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.